Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP)

Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP)

US Patent 6734184 · Granted May 11, 2004

Estimated economic value: $11,049,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

2,6,9-trisubstituted purines2025
POLQ inhibitors2025
Chemical compounds2024
Launching applications2024
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer2023
Pyridine and pyrimidine derivatives2022
Selective estrogen receptor down-regulators2021
Chemical compounds2021
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer2021
Chemical compounds2020
Chemical compounds2020
Selective estrogen receptor down-regulators2020